Decision rules: when to start, stop, and adjust interventions
A framework for making protocol decisions based on evidence quality, personal risk tolerance, and measurable outcomes.
Decision Rules
This file defines how protocol decisions are made in this repository.
Its purpose is not to automate judgment. Its purpose is to prevent drift.
A protocol framework becomes weak when decisions are made by impulse, excitement, prestige, or biomarker fascination instead of by clear rules.
This file exists so that protocol movement remains structured.
Core Position
A protocol decision is justified only when the intervention has earned it.
That means no intervention should enter, escalate, or remain in protocol structure simply because:
- it sounds advanced
- it has strong public attention
- it produces attractive molecular language
- it fits a preferred theory
- it looks more ambitious than the foundation layer
A protocol decision should happen only when the intervention satisfies the standards already established in the repository.
Governing Rules Already Established
This file inherits several rules that are already settled elsewhere in the repository:
Rule 1 | Function takes precedence when biomarkers conflict with it
If a molecular biomarker and a functional or physiological measure disagree, function takes precedence.
Rule 2 | Foundation outranks novelty
Exercise, high-quality dietary patterning, and sleep and recovery treatment logic are the current strongest foundation interventions because they already improve the things aging actually costs.
Rule 3 | Risk is part of intervention quality
An intervention is weaker, not stronger, if its risk, burden, or translation fragility exceeds its real organismal benefit.
Rule 4 | Support must remain support
A support intervention only belongs if it helps the foundation hold better, fit better, or work better.
Rule 5 | Exploratory does not mean protocol-relevant
An intervention can be scientifically important and still remain below protocol threshold.
Main Protocol Decisions
This repository needs rules for several different kinds of decisions.
1. Entry decision
Should this intervention enter protocol structure at all?
2. Layer decision
If it enters, does it belong in:
- foundation
- support
- exploratory only
3. Escalation decision
Should the intervention move upward in protocol significance?
4. Retention decision
Should it remain in the protocol, or has the evidence, burden, or function case weakened?
5. Combination decision
Does it belong in combination with something else, or is that just stacking?
Entry Rules
An intervention should enter protocol structure only if most of the following are true:
- the mechanism is plausible enough to matter
- the target logic is clear enough to specify
- the evidence is strong enough to justify structured use
- the risk profile is explicit
- the burden is manageable
- the intervention can be interpreted without depending on biomarker fantasy
- the intervention has some meaningful relationship to function, resilience, recovery, or capacity
If these conditions are not met, the intervention remains outside protocol structure.
Foundation-Layer Rules
An intervention belongs in the foundation layer only if it meets nearly all of the following:
- strong human functional evidence
- clear effect on capacity, resilience, recovery, or long-horizon health
- lower interpretation risk
- lower biological risk relative to more ambitious layers
- practical real-world use
- clear value even when biomarker support is incomplete
At the current stage of the repository, this logic supports:
- exercise
- high-quality dietary patterning
- sleep and recovery treatment logic
Nothing else should be promoted into the foundation layer without evidence strong enough to compete with those.
Support-Layer Rules
An intervention belongs in the support layer only if:
- it strengthens the foundation rather than replacing it
- it addresses a specific bottleneck
- it improves fit, adherence, resilience, recovery, or function
- its burden is justified by its contribution
- its value is clear in relationship to the base
A support intervention should be excluded if it:
- mainly adds complexity
- mainly adds biomarkers
- competes with the foundation for attention
- cannot explain what it is supporting
Exploratory-Layer Rules
An intervention belongs in the exploratory layer if:
- it is biologically important
- it is still limited by evidence, interpretation, risk, or translation
- it does not yet have enough human functional grounding for structured use
- it still deserves active tracking
An exploratory intervention should not be promoted unless multiple things improve at once:
- stronger human evidence
- clearer function
- clearer biomarker-function alignment
- lower or better-bounded risk
- better population-fit clarity
Escalation Rules
An intervention should move upward in protocol relevance only when it shows meaningful improvement in the domains that matter most.
Escalation requires some combination of:
- stronger functional evidence
- clearer resilience benefit
- clearer recovery benefit
- better human evidence
- lower interpretation ambiguity
- better risk control
- stronger fit across real populations
- better alignment between biomarkers and organismal outcomes
Escalation should not happen because of:
- better marketing language
- stronger molecular prestige
- one favorable biomarker shift
- one promising pilot without broader support
De-escalation Rules
An intervention should move downward or be removed when:
- function does not improve meaningfully
- burden exceeds benefit
- risk becomes clearer and worse
- adherence collapses
- biomarker movement no longer looks trustworthy
- foundation quality is being displaced
- the intervention adds noise rather than clarity
This repository should allow downward movement just as clearly as upward movement.
A protocol that only escalates becomes dishonest.
Combination Rules
A combination should be allowed only if it improves at least one of the following:
- bottleneck coverage
- function
- resilience
- recovery
- tolerability
- durability
A combination should be rejected if it mainly creates:
- redundant mechanism
- increased burden
- attribution collapse
- higher risk without clearer organismal gain
- biomarker complexity without functional improvement
The default rule is not “add until satisfied.” The default rule is “justify every added layer.”
Biomarker Use Rules
Biomarkers can support protocol decisions, but they do not rule them.
Biomarkers should be used to:
- clarify direction
- identify burden
- suggest mechanism
- monitor response
- detect mismatch between theory and organismal outcome
Biomarkers should not be used to:
- override function
- justify escalation by themselves
- hide weak real-world outcomes
- create the illusion of confidence where confidence is not earned
If biomarkers and function disagree, function decides.
Function Rules
Functional and physiological measures have special weight in this repository.
A protocol change gains credibility when it improves:
- grip strength
- gait speed
- cardiorespiratory fitness
- recovery quality
- frailty-related burden
- physical capacity
- resilience under stress
- cognitive or daily-life function where relevant
A protocol loses credibility when those things remain unchanged while the molecular story becomes more elaborate.
Risk Rules
Risk must be stated, not implied.
Every protocol decision should specify:
- main biological risk
- main interpretation risk
- main translation risk
- main implementation risk
- main population-fit limit
If those are not clear, the intervention is not ready for structured use.
Population-Fit Rules
No intervention should be treated as universally appropriate by default.
Every protocol decision should ask:
- who is this for
- who is it not for
- what baseline burden changes the fit
- what recovery capacity changes the fit
- whether the intervention is more credible in high-burden or healthy adults
- whether age, frailty, disease context, or functional status alter the logic
Protocol design without population fit is weak design.
Burden Rules
Burden is part of protocol quality.
An intervention is weaker when:
- it is too hard to sustain
- it reduces adherence to the foundation
- it interferes with recovery
- it creates more complexity than usable value
- it raises total load without improving function
A lower-burden intervention with the same functional outcome should usually outrank a more complex one.
Default Decision Order
When deciding what to do with an intervention, the repository should ask in this order:
- Does it improve real function, resilience, recovery, or capacity?
- Does it fit the intended population?
- Is the risk profile explicit and acceptable?
- Does it strengthen the foundation or only compete with it?
- Are the biomarkers supportive rather than misleading?
- Is the implementation burden realistic?
- Has it earned its protocol layer?
That order is deliberate. It keeps the protocol human-centered instead of biomarker-centered.
Relationship to the Rest of the Repository
This file is directly constrained by:
01_foundation_layer
because foundation rules set the protocol base
02_support_layer
because support rules define what counts as reinforcement
03_exploratory_layer
because exploratory status blocks premature promotion
02_BIOMARKERS/08_validation_and_translation_constraints
because biomarker limits shape decision strength
03_INTERVENTIONS/12_risk_hierarchy_and_translation_limits
because risk is part of every protocol decision
08_NOTES | Emerging Patterns
especially Pattern 6 and Pattern 7, because function and visible intervention
hierarchy already constrain what can be decided here
Current Assessment
Current repository assessment:
- importance to protocol structure: foundational
- importance to escalation control: foundational
- importance to translational honesty: foundational
- relevance to the entire protocol section: system-wide
Open Questions
- What minimum amount of functional improvement should count as meaningful for protocol escalation?
- How should disagreement between different functional measures be handled?
- When should a supportive intervention be removed even if it remains biologically plausible?
- How much biomarker support is enough to matter when function is improving but mechanism remains unclear?
Status
Foundational protocol-governance file.
This file should be treated as the rule layer that keeps protocol design structured, selective, and honest, not as optional guidance and not as a substitute for judgment.